Research
Hormonal
Soy protein improves insulin sensitivity and reduces hepatic lipogenesis by downregulating SREBP-1 and upregulating PPAR-alpha pathways.
Soy protein may help manage fat storage at a cellular level by reducing the genes responsible for making fat (SREBP-1) and increasing those responsible for burning fat (PPAR-alpha). This suggests soy protein is metabolically favorable for managing obesity-related metabolic syndrome.
GoodSupportsHIGH confidence
Soy protein feeding was shown to reduce the expression of the hepatic SREBP-1... and its target genes – fatty acid synthase (FAS)... Soy protein intake may limit adiposity by reducing the number of dysfunctional adipocytes possibly as a result of low lipogenesis.
Why this rating
Strong evidence from animal models (rats/mice) showing gene expression changes.
Source
Role of Dietary Soy Protein in Obesity
Manuel T. Velasquez et al. · International Journal of Medical Sciences · 2007
DOI 10.7150/ijms.4.72
narrative_reviewCited 308×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →